Bristol-Myers Squibb (NYSE: BMY) and Five Prime Therapeutics, Inc. (Nasdaq: FPRX) announced that they have entered into an exclusive clinical ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE